Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

6(66.7%)

Phase 1

1(11.1%)

Phase 2

1(11.1%)

Phase 3

1(11.1%)

9Total

N/A(6)

Phase 1(1)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT02972281Not ApplicableCompleted

Systematic Search for Primary Immunodeficiency in Adults With Infections

Role: collaborator

NCT06882265Not ApplicableRecruiting

Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy

Role: collaborator

NCT06097026Not ApplicableRecruiting

Role of Inhaled Nitric Oxide in Vascular Mechanics and Right Ventricular Function

Role: collaborator

NCT04925739Completed

Evaluation of the Comfort of a Continuous Positive Airway Pressure Nasal Mask in the Treatment of OSA Syndrome

Role: collaborator

NCT05029349Not ApplicableUnknown

Exploration of the VOLATOLOM in the Stable Severe COPD (Chronic Obstructive Pulmonary Disease)

Role: collaborator

NCT04816695Not ApplicableUnknown

Volatolom Variation in Severe COPD During Hospitalization for Exacerbation and After Hospitalization (VOC-BPCO-Exa)

Role: collaborator

NCT00919126Phase 3Terminated

General Anesthesia With Xenon in Inspiratory Concentrations of 50% and 70% and Total I.V. Anaesthesia.

Role: lead

NCT00801307Phase 1Completed

Trial Comparing Effect of He/O2 to Medical Air on Pulmonary Function Disease

Role: lead

NCT01355809Phase 2Terminated

Six-Minute Walk Test Comparing Helium/Oxygen to Nitrogen/Oxygen for COPD Rehabilitation

Role: lead

NCT00800072Not ApplicableCompleted

NOWOX Oxygen Therapy Monitoring Device

Role: lead

All 10 trials loaded